Clinical Trial Update: Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing Biphasic Human Insulin with EX1000 in Type 2 diabetes completed, assessing safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Biphasic human insulin (insulin human biphasic)
• EX1000

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED